Michael Stephens

Michael Stephens is a Senior Scientist at AstraZeneca, specializing in biologics engineering and next generation sequencing. Prior to this role, they served as a Scientist and subsequently as a Senior Scientist in NGS Process Development at Azenta Life Sciences, where they led the development of new services and collaborated with cross-functional teams. Michael completed a postdoctoral research associate position at Cornell University, contributing to strategies for managing invasive whitefly pests through next generation sequencing. They earned a PhD in Molecular Biology and Microbiology from the University of Connecticut and a Bachelor's degree in Biology from the University of North Florida.